| 原料品名 | linaclotide |
|---|---|
| 原料中文名称 | 利那洛肽 |
| 中文别名 | 利拉洛肽;利那洛肽-多肽原料;利那洛肽-多肽制剂;利那洛肽;醋酸利那洛肽 851199-59-3;醋酸利那洛肽;LINACLOTIDE 利那洛肽;利那洛肽,醋酸利那洛肽 |
| 化学名称 | (2S)-2-[[(1R,4S,7S,13S,16R,21R,24R,27S,30S,33R,38R,44S)-21-amino-13-(2-amino-2-oxoethyl)-27-(2-carboxyethyl)-44-[(1R)-1-hydroxyethyl]-30-[(4-hydroxyphenyl)methyl]-4-methyl-3,6,12,15,22,25,28,31,40,43,46,51-dodecaoxo-18,19,35,36,48,49-hexathia-2,5,11,14,23,26,29,32,39,42,45,52-dodecazatetracyclo[22.22.4.216,33.07,11]dopentacontane-38-carbonyl]amino]-3-(4-hydroxyphenyl)propanoic acid |
| 分子式 | C59H79N15O21S6 |
| 分子量 | 1526.73646 |
| CAS号 | 851199-59-2 |
| 结构式图片 | 暂无权限 |
| 美国DMF登记 | 暂无权限 |
供应商信息
| 企业名称 | Auro Peptides Limited |
|---|---|
| 地址 | Water Mark Building,Plot No. 11,Survey No.9,Kondapur,Hitech City,Hyderabad – 500 084 Telangana,India. |
| 国家/地区 | 印度 |
| 公司官网 | 暂无权限 |
| 公司联系电话 | 暂无权限 |
| 公司邮箱 | 暂无权限 |
| 公司简介 | Auro Peptides Ltd. is the subsidiary division of Aurobindo Pharma that delivers innovative solutions from discovery to development and commercialization through to cost-effective drug development and manufacturing. Auro Peptide’s aims “to deliver cGMP material in a timely, transparent, reliable manner and in a facilitative environment, through streamlined processes and talented workforce.” Located approximately 40km from Hyderabad, the facility is supported by state-of-the-art infrastructure which enables end-to-end GMP services so as to deliver the services in line with customer expectations and regulatory requirements. The facility houses a highly experienced team of scientists who develop chemical synthesis processes for peptides which are commercially viable and eco-friendly. The entire manufacturing facility is HVAC controlled. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息（https://s.yaozh.com/Purchase/release），或联系药智通客服17318480790（微信同号） |
扩展信息
